Funder
Yunnan Provincial Science and Technology Department
Reference57 articles.
1. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat. Rev. Microbiol.,2020
2. COVID-19 vaccine development: milestones, lessons and prospects;Li;Signal Transduct. Targeted Ther.,2022
3. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial;Stuart;Lancet,2022
4. Correlates of adjuvanticity: a review on adjuvants in licensed vaccines;Del Giudice;Semin. Immunol.,2018
5. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review;Fiolet;Clin. Microbiol. Infection,2022